ClinicalTrials.Veeva

Menu

Nutrition in Gastrointestinal Tumors (NutriGIT)

U

University Medicine Greifswald

Status

Completed

Conditions

Oesophageal Cancer
Bile Duct Cancer
Gastric Cancer
Colon Cancer
Neuroendocrine Tumors
GIST, Malignant
Liver Cancer
Small Intestine Cancer
Rectal Cancer
Pancreatic Cancer

Treatments

Other: No intervention - observational study only

Study type

Observational

Funder types

Other

Identifiers

NCT04476082
BB 071/20

Details and patient eligibility

About

Malnutrition and loss of muscle mass frequently occur in patients undergoing chemotherapy and can negatively effect therapy outcome. Especially patients with cancer of the gastrointestinal tract are often affected by malnutrition. Therefore, this study aims to examine changes in nutritional status of patients with cancer of the gastrointestinal tract during chemotherapy. Findings of this study will help to improve nutritional treatment of patients undergoing chemotherapy.

Full description

Malnutrition and sarcopenia are common complications in patients with malignant diseases of the gastrointestinal tract. During chemotherapy there is a high risk of further impairment of nutritional status due to anorexia, nausea, emesis and other gastrointestinal conditions that adversely impact food assimilation or absorption. Findings on changes of nutritional status during chemotherapy are scarce but of paramount importance for adequate nutrition therapy. Therefore, this study aims to provide a detailed description of changes in nutritional status of patients with a malignant condition of the gastrointestinal tract during chemotherapy.

Enrollment

66 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with initial diagnosis of a malignant condition of the gastrointestinal tract planned to receive cytostatic treatment.
  • ongoing cytostatic treatment of a known malignant condition of the gastrointestinal tract

Exclusion criteria

  • pregnancy
  • history of any other malignant tumor disease
  • inability to provide consent

Trial design

66 participants in 2 patient groups

Initial Diagnosis
Description:
Patients with initial diagnosis of a malignant condition of the gastrointestinal tract planned to receive cytostatic treatment.
Treatment:
Other: No intervention - observational study only
Ongoing Cytostatic Treatment
Description:
Patients with a malignant condition of the gastrointestinal tract already receiving cytostatic treatment.
Treatment:
Other: No intervention - observational study only

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems